$1.64
0.000.00%
At close: -
$1.60
-0.04-2.44%
After Hours: Dec 19, 9:20 AM EDT
Comments
Loading...
PharmaCyte Biotech (NASDAQ:PMCB) Stock, Guidance And Forecast
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
Data brought to you by Benzinga APIs
FAQ
What is the most recent guidance for PharmaCyte Biotech (PMCB)?
The most recent guidance for PharmaCyte Biotech (PMCB) was reported on July 11, 2022 for the full year 2022. The company provided earnings per share guidance in the range of $-0.27 to $-0.27, compared to the estimated EPS of $-0.24. Additionally, PharmaCyte Biotech forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.